Le Lézard
Classified in: Health, Business
Subjects: DIS, CXP, DEI

Autism Learning Partners Opens Its 3rd Location in New York to Serve the Yonkers Community


YONKERS, N.Y., July 29, 2021 /PRNewswire-PRWeb/ -- Autism Learning Partners (ALP), a national leader that specializes in the treatment of autism and other developmental disabilities, is pleased to announce its in-state expansion with the addition of the Yonkers, New York location. ALP initiated this extension in response to the need for quality in-home support with flexible scheduling as well as support in the community with an emphasis on social skills. The Yonkers location will join the existing three offices effectively serving the state. ALP is committed to continuing its collaborative efforts with other service providers in the Yonkers area to ensure consistency of care. ALP is steadfast in its dedication to providing resources to families and communities who need support.

ALP strives to give hope, support, and paths of progress for children and their families living with autism and related disorders. With their vast network of community partnerships and ever-growing list of accepted insurances, families can receive quality support. ALP believes that a tailored, comprehensive care plan with a dedicated clinical team allows children and their family units to experience the most progress possible.

"We have enjoyed supporting families in Albany, Buffalo, and Rochester for over 7 years. We are grateful for the opportunity to expand our services to additional New York communities such as Yonkers with more to come," said Gina T. Chang, Ph.D., BCBA-D, CEO of ALP.

ALP is a national leader in the special needs field for over 30 years. They are headquartered in Pasadena, CA, employs over 300 Board Certified Behavior Analysts ("BCBAs") and has a total workforce of 3,000, including Behavior Technicians providing in-home and in-clinic ABA-based care across the country. Services include: Applied Behavioral Analysis and additionally offer speech, occupational, physical therapies, and diagnostic services in select regions. Treatment is now offered in 19 states including California, Colorado, Connecticut, Florida, Georgia, Indiana, Maryland, Massachusetts, Michigan, New Jersey, New Mexico, North Carolina, Ohio, Oregon, Rhode Island, Texas, Utah, and Washington.

To learn more about Autism Learning Partners and its services, please visit AutismLearningPartners.com.

Media Contact

Rahil Roussos, Autism Learning Partners, 310-938-7648, [email protected]

Facebook

 

SOURCE Autism Learning Partners


These press releases may also interest you

at 18:05
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to...

at 17:35
Genmab A/S today announced new efficacy and safety data from two ongoing Phase 1/2 clinical trials evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, in adult patients with certain types of follicular lymphoma...

at 14:35
Positive results from the LAURA Phase III trial showed AstraZeneca's TAGRISSO® (osimertinib) demonstrated a statistically significant and highly clinically meaningful improvement in progression-free survival (PFS) for patients with unresectable,...

at 12:35
CatalYm today announced positive new follow-up results from its ongoing "GDFATHER" Phase 1/2a trial (GDF-15 Antibody-mediaTed Human Effector Cell Relocation Phase 1/2a) (NCT04725474) in an oral presentation at the American Society of Clinical...

at 11:35
In an era where healthcare innovation is paramount, KFSHRC Jeddah has made headway in the treatment of severe Xanthoma through the deployment of a modified plasma exchange protocol. This milestone underscores KFSHRC's position as a trailblazer in...

at 11:00
GSK plc (LSE/NYSE: GSK) today announced positive results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating belantamab mafodotin, in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care,...



News published on and distributed by: